This funding opportunity supports biphasic research projects evaluating the impact of HIV immunotherapies on central nervous system outcomes in people with HIV. It focuses on identifying mechanisms, benefits, and risks associated with these therapies in the CNS compartment, addressing barriers like blood brain barrier penetration and viral dynamics. The goal is to inform safe and effective targeting of CNS HIV persistence and improve long-term neurologic and cognitive outcomes.
Eligible applicants include a wide range of organizations such as state, county, city, and tribal governments, public and private institutions of higher education, nonprofits, for-profit organizations, small businesses, and federal agencies. Specific eligibility details are provided in the full anno
